Skip to content

Assessment of the protective effect of sunscreen by measuring UV-biomarkers

Assessment of the protective effect of sunscreen by measuring UV-biomarkers

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25722
Enrollment
12
Registered
2019-10-17
Start date
2019-10-03
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Repeated UVR exposure of the back skin during 5 days (Monday to Friday). The UVR dose on the sunscreen protected skin will be 150 mJ/cm2 (approximately 5 MED). Two different sunscreens with a declared

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Between 18 and 65 years of age - Fitzpatrick skin type II or III - Free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator - Individual who has read, understood, and signed an informed consent document relating to the specific study to which he/she is subscribing - Willingness to actively participate in the study and come to the scheduled visits - Willingness to discontinue the use of detergents (e.g. soaps) and cosmetics products (e.g. creams, moisturizers) in the treatment area throughout the course of the study - Willingness to avoid any exposure of the test area to artificial or natural ultraviolet light throughout the course of the study - Individual with no known abnormal response to sunlight (e.g. polymorphic eruption) or to sunscreen (ingredients of sunscreen)

Exclusion criteria

Exclusion criteria: - Taking medication which in the opinion of the investigator would mask or interfere with the results - With chronic skin allergies - With suntan of sunburn - Breastfeeding - Pregnancy or the intention to become pregnant over the duration of the study - Participation in, or being in the waiting period for another study - Individual with moles, tattoos, scars, irritated skin, hairs, etc. at the test area that could influence the investigation.

Design outcomes

Primary

MeasureTime frame
Urocanic acid isomers, immunological mediators, and angiogenesis factors in the stratum corneum at baseline and after UVR.

Contacts

Public ContactAnne Keurentjes

Amsterdam UMC, locatie AMC

a.j.keurentjes@amsterdamumc.nl020-5665326

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)